| Original language | English (US) |
|---|---|
| Pages (from-to) | 1656-1658 |
| Number of pages | 3 |
| Journal | Headache |
| Volume | 59 |
| Issue number | 9 |
| DOIs | |
| State | Published - Oct 1 2019 |
Keywords
- education
- migraine
- online
- social media
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Headache, Vol. 59, No. 9, 01.10.2019, p. 1656-1658.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Online Migraine Education and Support for Patients
T2 - Perspectives from the American Headache Society Emerging Leaders Program
AU - VanderPluym, Juliana H.
AU - Hamilton, Katherine
AU - Hindiyeh, Nada A.
AU - Robbins, Matthew S.
AU - Starling, Amaal J.
AU - Vargas, Bert B.
AU - Gibbons, Sarah K.
AU - Vgontzas, Angeliki
N1 - Funding Information: Juliana H. VanderPluym MD VanderPluym.Juliana@mayo.edu Katherine Hamilton MD Nada A. Hindiyeh MD Matthew S. Robbins MD Amaal J. Starling MD Bert B. Vargas MD Sarah K. Gibbons DO Angeliki Vgontzas MD Mayo Clinic Scottsdale AZ USA University of Pennsylvania Philadelphia PA USA Stanford University Medical Center Palo Alto CA USA Weill Cornell Medical College New York NY USA University of Texas Southwestern Dallas TX USA Saint Luke's Health System Kansas City MO USA Graham Headache Center Brigham and Women’s Hospital Boston MA USA online migraine education social media Conflict of Interest: VanderPluym: Dr VanderPluym consults for Healint and Teva and has a research grant from Amgen. She serves on the New Investigator and Trainee Special Interest Section of the American Headache Society. Hamilton: Dr Hamilton consults for Guidepoint. Hindiyeh: Dr Hindiyeh is a speaker for Eli Lilly, Amgen, is on the advisory boards for Eli Lilly, Amgen, and Zosano. Robbins: Dr. Robbins serves on the Board of Directors for the American Headache Society, has received book royalties from Wiley and an editorial stipend from Springer. Starling: Dr. Starling has received compensation from serving on advisory boards and/or consulting within the past 5 years for: Alder, Amgen, Eli Lilly & Company, eNeura, and Novartis. Dr. Starling has received funding for travel and speaking from American Academy of Neurology and American Headache Society. Vargas: Dr Vargas is on the advisory board Amgen, Novartis, Allergan, Alder, Teva, Lilly, Upsher‐Smith, Biohaven, Promius; Speaker ATI; Board of Directors American Headache Society, Headache Cooperative of the Pacific; Editorial Board of Neurology Today. Gibbons: Dr Gibbons is a speaker for Lilly. Vgontzas: Dr Vgontzas has no conflicts. Financial Support: This is an unfunded study. The Emerging Leaders Program is a scholarship leadership training program sponsored by the American Headache Society that provided funding for complimentary registration to the Scottsdale Headache Symposium and expenses paid to attend.
PY - 2019/10/1
Y1 - 2019/10/1
KW - education
KW - migraine
KW - online
KW - social media
UR - http://www.scopus.com/inward/record.url?scp=85073126022&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073126022&partnerID=8YFLogxK
U2 - 10.1111/head.13649
DO - 10.1111/head.13649
M3 - Article
C2 - 31508808
AN - SCOPUS:85073126022
SN - 0017-8748
VL - 59
SP - 1656
EP - 1658
JO - Headache
JF - Headache
IS - 9
ER -